25-MAY-2024 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 148 48 0 0 0 0 0 07/25/2016    
        2 Cabozantinib   46 0 0 0 0 0      
        3 Crizotinib   28 0 0 0 0 0      
        4 Savolitinib   30 0 0 0 0 0      
            152 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 804 120 61 37 14 2 09/24/2018 330 138
            804 120 61 37 14 2      
 
    2 Y 1 Standard Systemic Therapy Only   283 39 18 12 6 1 09/24/2018    
        2 SST + Surgery/RT   282 40 19 11 3 0      
            565 79 37 23 9 1      
 
  S1931-RENAL, Stg IV, IO + Nephrectomy. vs IO Only 1 Y 0 Pre-Rand. SST 332 142 53 26 10 2 0 03/08/2021 209 78
            142 53 26 10 2 0      
 
    2 Y 1 Systemic Immuno. Only   52 23 13 5 2 0 03/08/2021    
        2 Nephrectomy + Systemic Immuno.   43 16 5 3 2 0      
            95 39 18 8 4 0      
 
  S1937-Blad, Mets, Eribulin + Gem vs SOC 1 Y 1 Physician Choice Chemo 184 12 4 4 4 1 0 06/28/2021 202 70
        2 Eribulin   8 1 0 0 0 0      
        3 Eribulin + Gemcitabine   11 4 4 4 3 1      
            31 9 8 8 4 1      
 
  S2200-pRCC, Adv, Cabo +/- Atezo 1 Y 1 Cabozantinib Only 200 9 7 5 3 1 0 03/24/2023 133 57
        2 Cabozantinib + Atezolizumab   9 8 5 4 1 1      
            18 15 10 7 2 1      
 
  S2210-Pros, High Risk, BRCA, Neoadj Carbo 1 Y 1 Carboplatin + Surgery 44 1 1 1 1 0 0 03/01/2024 120 38
            1 1 1 1 0 0      
 
Yes A031702-GU, Mets, Cabozantinib+Nivo+Ipi (ICONIC) 1 E Total Registrations   26 2 0 0 0 0 08/09/2019 227 92
            26 2 0 0 0 0      
 
  A031803-Blad, NMIBC, Gemcitabine + MK-3475 1 E Total Registrations   43 9 3 3 0 0 03/18/2020 128 56
            43 9 3 3 0 0      
 
  A032103-Urothelial, All Stg, MRD-Based Adj Tx 0 E Total Registrations   1 1 1 1 0 0 03/19/2024 123 38
            1 1 1 1 0 0      
 
    1 E Total Registrations   1 1 1 1 1 0 03/19/2024    
            1 1 1 1 1 0      
 
  EA8171-PROS, newly diagnosed, mpMRI for pre-op stagi 1 E Total Registrations   88 3 1 1 1 0 02/11/2019 89 48
            88 3 1 1 1 0      
 
  NRGGU008-Pros,Node+, Abiraterone acetate + Apalutamide 1 E Total Registrations   13 7 3 1 0 0 09/25/2020 227 83
            13 7 3 1 0 0      
 
  NRGGU011-Pros, Dbl Blinded RT +/- Androgen Dep Tx 1 E Total Registrations   9 8 6 1 0 0 03/29/2023 199 73
            9 8 6 1 0 0      
 
  NRGGU012-Renal, Stg IV, Stereo Abl Rad Therapy 1 E Total Registrations   3 3 3 1 1 0 01/10/2024 193 63
            3 3 3 1 1 0      
 
No A031701-Bladder, ddGC for MIBC with DDR Tumor Alt 1 E Total Registrations   20 5 2 1 0 0 12/17/2018 144 51
            20 5 2 1 0 0      
 
    2 E Total Registrations   17 5 3 1 0 0 12/17/2018    
            17 5 3 1 0 0      
 
    3 E Total Registrations   2 0 0 0 0 0 12/17/2018    
            2 0 0 0 0 0      
 
  A031801-GU, mRCC, Cabozantinib +/- Radium-223 1 E Total Registrations   14 5 2 0 0 0 11/06/2020 101 41
            14 5 2 0 0 0      
 
  EA8134-Penile, Local Adv, ILND +/- Chemo or ChemoRT 1 E Total Registrations   12 2 0 0 0 0 04/25/2019 38 15
            12 2 0 0 0 0      
 
  EA8191-Pros, Local vs Systemic Thrpy 0 E Total Registrations   37 21 14 9 8 2 09/24/2021 185 62
            37 21 14 9 8 2      
 
    1 E Total Registrations   37 21 14 9 8 2 09/24/2021    
            37 21 14 9 8 2      
 
  EA8192-Blad, High Grade UTUC, Durv + Chemo 1 E Total Registrations   3 1 1 1 0 0 02/23/2022 146 54
            3 1 1 1 0 0      
 
  EA8212-Blad, NMIBC, BRIDGE 1 E Total Registrations   110 89 57 28 6 2 02/07/2023 126 68
            110 89 57 28 6 2      
 
  NRGGU009-Pros, PREDICT-RT 1 E Total Registrations   57 39 20 15 8 1 03/01/2022 426 158
            57 39 20 15 8 1      
 
    2 E Total Registrations   53 37 24 13 7 3 03/01/2022    
            53 37 24 13 7 3      
 
  NRGGU010-Pros, Parallel De-Intens & Intens Trials 1 E Total Registrations   37 23 9 6 3 0 01/03/2022 425 160
            37 23 9 6 3 0      
 
    2 E Total Registrations   33 20 10 4 2 0 01/03/2022    
            33 20 10 4 2 0      
 

25-MAY-2024 6:10

GU Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
A032103 Urothelial, All Stg, MRD-Based Adj Tx 2 Re-Registration 09-Jan-24 123 38
EA8134 Penile, Local Adv, ILND +/- Chemo or ChemoRT 2 Randomization2 08-Sep-17 38 15